AQR Capital Management - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 84 filers reported holding VISTAGEN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,070
-95.7%
10,392
-47.7%
0.00%
Q1 2022$25,000
-86.7%
19,860
-79.4%
0.00%
Q4 2021$188,000
-62.2%
96,589
-46.8%
0.00%
-100.0%
Q3 2021$497,000
+43.6%
181,440
+65.4%
0.00%0.0%
Q2 2021$346,000109,7030.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders